 "Capsules; Image Courtesy: Siegfried")
After receiving an approval from the US Food and Drug Administration (FDA), Lupin Limited has launched its Amabelz (estradiol and norethindrone acetate) tablets in two strengthens - 0.5 mg / 0.1 mg and 1 mg / 0.5 mg – in the US. Amabelz is the generic equivalent of Amneal Pharmaceuticals’ Activella tablet.
Amabelz tablets are indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis. The tablet in strengthen of 1 mg / 0.5 mg is also indicated in a woman with a uterus for treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.
Activella had US sales of $ 91.1 million, according to IMS MAT June 2016.
